131 related articles for article (PubMed ID: 25825704)
1. CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors.
Martins MB; Marcello MA; Batista Fde A; Cunha LL; Morari EC; Soares FA; Vassallo J; Ward LS
J Immunol Res; 2014; 2014():921864. PubMed ID: 25825704
[TBL] [Abstract][Full Text] [Related]
2. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
[TBL] [Abstract][Full Text] [Related]
3. P53 and expression of immunological markers may identify early stage thyroid tumors.
Marcello MA; Morari EC; Cunha LL; De Nadai Silva AC; Carraro DM; Carvalho AL; Soares FA; Vassallo J; Ward LS
Clin Dev Immunol; 2013; 2013():846584. PubMed ID: 24171036
[TBL] [Abstract][Full Text] [Related]
4. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
[TBL] [Abstract][Full Text] [Related]
5. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
[TBL] [Abstract][Full Text] [Related]
6. Expression of MAGE-A4 and MAGE-C1 tumor-associated antigen in benign and malignant thyroid diseases.
Melo DH; Mamede RC; Neder L; Saggioro FP; Figueiredo DL; da Silva WA; Jungbluth AA; Zago MA
Head Neck; 2011 Oct; 33(10):1426-32. PubMed ID: 21246638
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma.
Cunha LL; Morari EC; Guihen AC; Razolli D; Gerhard R; Nonogaki S; Soares FA; Vassallo J; Ward LS
Clin Endocrinol (Oxf); 2012 Dec; 77(6):918-25. PubMed ID: 22738343
[TBL] [Abstract][Full Text] [Related]
8. Expression of MAGE-A3/6 in primary breast cancer is associated with hormone receptor negative status, high histologic grade, and poor survival.
Ayyoub M; Scarlata CM; Hamaï A; Pignon P; Valmori D
J Immunother; 2014; 37(2):73-6. PubMed ID: 24509169
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.
Pan SH; Su KY; Spiessens B; Kusuma N; Delahaye NF; Gruselle O; Myo A; de Creus A; Louahed J; Chang GC; Yu SL; Yang PC
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e212-e223. PubMed ID: 27519286
[TBL] [Abstract][Full Text] [Related]
10. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
11. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation.
Chen A; Santana AL; Doudican N; Roudiani N; Laursen K; Therrien JP; Lee J; Felsen D; Carucci JA
PLoS One; 2020; 15(11):e0241551. PubMed ID: 33227008
[TBL] [Abstract][Full Text] [Related]
12. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
[TBL] [Abstract][Full Text] [Related]
13. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.
Thongprasert S; Yang PC; Lee JS; Soo R; Gruselle O; Myo A; Louahed J; Lehmann FF; Brichard VG; Coche T
Lung Cancer; 2016 Nov; 101():137-144. PubMed ID: 27794402
[TBL] [Abstract][Full Text] [Related]
15. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
16. Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study.
Sienel W; Varwerk C; Linder A; Kaiser D; Teschner M; Delire M; Stamatis G; Passlick B
Eur J Cardiothorac Surg; 2004 Jan; 25(1):131-4. PubMed ID: 14690745
[TBL] [Abstract][Full Text] [Related]
17. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
Ha EJ; Baek JH; Lee JH; Song DE; Kim JK; Shong YK; Hong SJ
Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
[TBL] [Abstract][Full Text] [Related]
18. HLA-G is differentially expressed in thyroid tissues.
de Figueiredo Feitosa NL; Crispim JC; Zanetti BR; Magalhães PK; Soares CP; Soares EG; Neder L; Donadi EA; Maciel LM
Thyroid; 2014 Mar; 24(3):585-92. PubMed ID: 24089994
[TBL] [Abstract][Full Text] [Related]
19. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation.
Cunha LL; Marcello MA; Morari EC; Nonogaki S; Conte FF; Gerhard R; Soares FA; Vassallo J; Ward LS
Endocr Relat Cancer; 2013 Feb; 20(1):103-10. PubMed ID: 23193072
[TBL] [Abstract][Full Text] [Related]
20. Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
Lerut E; Van Poppel H; Joniau S; Gruselle O; Coche T; Therasse P
Int J Clin Exp Pathol; 2015; 8(8):9522-32. PubMed ID: 26464715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]